Join the global movement on International Epilepsy Day 2025. Learn about the WHO’s IGAP, share your Epilepsy Journey, and ...

UCLA Health launches a pilot study to assess if a ketogenic diet with mood stabilizers improves bipolar disorder symptoms in ...

Popular GLP-1 medications like semaglutide and tirzepatide have been linked to rare vision issues, including NAION, raising ...

Explore how psychosocial and physical stress affects cfDNA release in blood and saliva. Discover gender differences and ...

Is cannabis use during pregnancy safe? No, the use of tetrahydrocannabinol (THC) and cannabidiol (CBD) may affect your baby's ...

People unconsciously cheat to feel smarter or healthier, deceiving themselves into believing their success is due to ability ...

The surge of Anti-Obesity Medications is reshaping eating habits and opening new opportunities for the food industry to ...

Test your knowledge on biomarkers and molecular markers, their roles in health, disease, and treatment response in this ...

CNW/ - Pharmascience Canada is proud to announce the launch of  Pr  pms-RUPATADINE (rupatadine), a treatment that helps relieve nasal and non-nasal ...

KeyMed Biosciences (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the supplemental New Drug Application (the "sNDA") of ...

TheraSyn Bio and Rubix LS have announced a groundbreaking joint venture, Project Panacea, to develop a topical breast cancer therapy.

Report on how AI is redefining market landscape - The global effervescent tablet market size is estimated to grow by USD 4.80 billion from 2024-2028, according to Technavio. The market is estimated to ...